Fabrice Lejeune

12PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsRehabilitation engineeringMedical virologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 01, 2026
Comparative evaluation of TRIDs : a strategy to improve treatments.

Fatima Hariss, Sacha Spelier, Louise Damy

|Jul 23, 2025
Screening Methods for NMD Inhibitors or Readthrough Activators.

Selma Nedjma, Fabrice Lejeune

|May 21, 2025
Retroviral adapters hijack the RNA helicase UPF1 in a CRM1/XPO1-dependent manner and reveal proviral roles of UPF1.

Léa Prochasson, Makram Mghezzi-Habellah, Armelle Roisin

|Mar 28, 2024
Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons.

Nesrine Benslimane, Camille Loret, Pauline Chazelas

|Oct 28, 2023
Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System.

Julie Carrard, Fiona Ratajczak, Joséphine Elsens

|Jul 29, 2023
Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot-Marie-Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene.

Nesrine Benslimane, Federica Miressi, Camille Loret

Pageof 2

Frequent Collaborators

2 joint publications

Anne-Sophie Lia

2 joint publications

Frédéric Favreau

2 joint publications

Nesrine Benslimane

2 joint publications

Camille Loret